Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies.

Chebib, Fouad T; Zhou, Xiaolei; Garbinsky, Diana; Davenport, Eric; Nunna, Sasikiran; Oberdhan, Dorothee; Fernandes, Ancilla

Chebib, Fouad T; Zhou, Xiaolei; Garbinsky, Diana; Davenport, Eric; Nunna, Sasikiran; Oberdhan, Dorothee; Fernandes, Ancilla.

Afiliação

Chebib FT; Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL.
Zhou X; RTI Health Solutions, Research Triangle Park, NC.
Garbinsky D; RTI Health Solutions, Research Triangle Park, NC.
Davenport E; RTI Health Solutions, Research Triangle Park, NC.
Nunna S; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD.
Oberdhan D; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD.
Fernandes A; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD.

Kidney Med ; 5(6): 100639, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37250503

Palavras-chave

Autosomal dominant polycystic kidney disease (ADPKD); clinical trial; glomerular filtration rate (GFR); subgroup analysis; tolvaptan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google